> ## Content Index > Fetch the complete content index at: https://members.americanhealthintel.com/llms.txt > Use this file to discover other available public pages before exploring further. # Your week in healthcare: Tenet call on the $5.7B Surgery Partners sale - URL: https://members.americanhealthintel.com/weekly-2026-11-06/ - Published: 2026-11-06T22:00:00.000Z - Updated: 2026-11-06T21:59:59.000Z - Description: 85 stories this week. The five that matter most, and what's coming next week. - Author: American Health Intel 85 stories this week. The five that matter most, and what's coming next week. | American Health Intel The week · Rules · Money · Medicine Weekly summary Oct 30 to Nov 6, 2026 The week in American healthcare 85 stories this week. The five that matter most, and what's coming next week. ![](https://americanhealthintel.com/email/pulse-divider.png) 85 stories reported $1.1B taken back in enforcement $17.8B in disclosed deals 29 rules on the move The five that matter 01 · Deal · $5.7B · Sat Oct 31 [Tenet call adds context to $5.7B Surgery Partners sale](https://americanhealthintel.com/editions/2026-10-31-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=weekly#healthspan-partners-surgery-partners-acquisition) A nonprofit health system is buying one of the largest surgery center companies, and an analyst says nonprofits are paying more than the market gives Tenet's USPI. [READ THE STORY →](https://americanhealthintel.com/editions/2026-10-31-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=weekly#healthspan-partners-surgery-partners-acquisition) 02 · Deal · $3.9B · Sun Nov 1 [Select Medical files late notice of material change in Massachusetts](https://americanhealthintel.com/editions/2026-11-01-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=weekly#select-medical-massachusetts-late-notice) A deal can clear federal antitrust review and still owe the state a timely notice. Watch whether the Health Policy Commission opens a Cost and Market Impact Review. [READ THE STORY →](https://americanhealthintel.com/editions/2026-11-01-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=weekly#select-medical-massachusetts-late-notice) 03 · Deal · $2.4B · Sun Nov 1 [Cencora's American Oncology Network deal has no close date](https://americanhealthintel.com/editions/2026-11-01-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=weekly#cencora-american-oncology-network-acquisition) A drug distributor is buying a large community cancer network, a sign of consolidation in oncology. Watch the November 4 earnings call for timing. [READ THE STORY →](https://americanhealthintel.com/editions/2026-11-01-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=weekly#cencora-american-oncology-network-acquisition) 04 · Rule · Fri Nov 6 [Medicare drug price negotiation gets a permanent final rule](https://americanhealthintel.com/editions/2026-11-06-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=weekly#ira-negotiation-final-rule-cms-4215) Medicare's drug price negotiation now runs on a permanent rule instead of guidance, so the program continues past 2028\. Watch the February 1, 2027 selection list. [READ THE STORY →](https://americanhealthintel.com/editions/2026-11-06-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=weekly#ira-negotiation-final-rule-cms-4215) 05 · Rule · Thu Nov 5 [2027 physician pay rate falls](https://americanhealthintel.com/editions/2026-11-05-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=weekly#cy2027-conversion-factor-cut) Doctors who bill Medicare face a lower per-service rate in 2027 because a one-year boost from Congress runs out. Watch whether Congress acts again before January 1. [READ THE STORY →](https://americanhealthintel.com/editions/2026-11-05-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=weekly#cy2027-conversion-factor-cut) Coming up next week Tue Nov 10 ExpiresCDC Order Continuing Suspension of Entry from Countries with Quarantinable DiseaseThu Nov 12 Comment close2027 Supplement to the Physical Activity Guidelines for AmericansThu Nov 12 Comment closeCY 2027 Medicare Shared Savings Program final rule provisionsThu Nov 12 Dairy objections dueStandards of Identity Salt Substitutes Final RuleThu Nov 12 Dairy objections dueUse of Salt Substitutes To Reduce the Sodium Content in Standardized FoodsThu Nov 12 Hemp thc ban delay fromContinuing resolution (H.R. 6500) funding the federal government through December 11, 2026 [Read every edition this week](https://americanhealthintel.com/editions/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=weekly) You get this summary every Friday at 5pm Eastern. Want every edition instead? Switch to daily, or unsubscribe, from the links below. Reply to tell us what you want covered. News and analysis, not legal, medical, coding, or investment advice.You subscribed at americanhealthintel.com · [Unsubscribe](%%{unsubscribe%5Furl}%%) | | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |